This topic contains a solution. Click here to go to the answer

Author Question: For the crime of extortion, the threat need not be communicated in the actual, physical presence of ... (Read 94 times)

Kikoku

  • Hero Member
  • *****
  • Posts: 540
For the crime of extortion, the threat need not be communicated in the actual, physical presence of the victim.
 
  a. True
  b. False
  Indicate whether the statement is true or false

Question 2

If the threat is to inflict harm in the future, the offense charged will be robbery rather than extortion.
 
  a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

SamMuagrove

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

TRUE

Answer to Question 2

FALSE




Kikoku

  • Member
  • Posts: 540
Reply 2 on: Aug 16, 2018
YES! Correct, THANKS for helping me on my review


gcook

  • Member
  • Posts: 343
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

The average older adult in the United States takes five prescription drugs per day. Half of these drugs contain a sedative. Alcohol should therefore be avoided by most senior citizens because of the dangerous interactions between alcohol and sedatives.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library